Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free
Axsome Therapeutics NASDAQ AXSM
$74.89 1.13 1.51%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 25 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

3.54B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
3.34B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
2.23
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
47.33M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-5.91 %
Upcoming events Axsome Therapeutics All events
No upcoming events scheduled
Overview Financials Key Metrics Dividends Industry overview Events

Stock chart Axsome Therapeutics

Stock analysis Axsome Therapeutics

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-14.82 35.52
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
18.56 13.63
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-14.86 17.42
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.92 0.37
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-125.27 8.90

Price change Axsome Therapeutics per year

19.38$ 87.24$
Min Max

Summary analysis Axsome Therapeutics

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Axsome Therapeutics

Revenue and net income Axsome Therapeutics

All parameters
Stock news Axsome Therapeutics All news
28 June 2023 в 16:50

Axsome Therapeutics Shares Drop 11% After Public Offering Prices

28 June 2023 в 16:45

Axsome Therapeutics Shares Drop 11% After Public Offering Prices

28 November 2022 в 18:55

Axsome Therapeutics Shares Hit 52-Week High, Propelled by Alzheimer's Study >AXSM

28 November 2022 в 18:51

Axsome Therapeutics Shares Hit 52-Week High, Propelled by Alzheimer's Study >AXSM

19 August 2022 в 14:10

Axsome Therapeutics: FDA Approves Auvelity to Treat Major Depressive Disorder in Adults

19 August 2022 в 14:10

Axsome Therapeutics: FDA Approves Auvelity to Treat Major Depressive Disorder in Adults

27 June 2022 в 18:40

Axsome Therapeutics Shares Leap on Renewed AXS-05 Hopes >AXSM

27 June 2022 в 18:35

Axsome Therapeutics Shares Leap on Renewed AXS-05 Hopes >AXSM

25 April 2022 в 17:56

Axsome Therapeutics Shares Slide as FDA Rejection of AXS-07 Looms >AXSM

25 April 2022 в 17:56

Axsome Therapeutics Shares Slide as FDA Rejection of AXS-07 Looms >AXSM

19 April 2022 в 17:25

Axsome Therapeutics Shares Rally After Positive AXS-05 Update >AXSM

19 April 2022 в 17:20

Axsome Therapeutics Shares Rally After Positive AXS-05 Update >AXSM

28 March 2022 в 13:35

Axsome Therapeutics to Buy Sunosi From Jazz Pharmaceuticals

28 March 2022 в 13:31

Axsome Therapeutics to Buy Sunosi From Jazz Pharmaceuticals

18 October 2021 в 18:05

What’s Happening With Axsome Therapeutics Stock?

20 September 2021 в 13:35

Axsome Therapeutics Stock Rises 36% In A Month But Will The Rally Continue?

9 September 2021 в 17:45

Axsome Therapeutics Inc Ranked Among Today’s Top Shorts After The European Central Bank Says It May Slow Down Bond Purchases

10 August 2021 в 16:59

Axsome Therapeutics stock price target cut to $55 from $118 at Mizuho

16 December 2019 в 18:44

-Лидеры и аутсайдеры Уолл-cтрит: Boeing, Axsome Therapeutics, Western Digital, PG&E

About company Axsome Therapeutics

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. Its product pipeline includes AXS-05 for the treatment major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial for the treatment of Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation. The company is also developing AXS-07 for the treatment of migraine; AXS-12 for the treatment of narcolepsy; and AXS-14 for the treatment of fibromyalgia. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.
Address:
22 Cortlandt Street, New York, NY, United States, 10007
Company name: Axsome Therapeutics
Issuer ticker: AXSM
ISIN: US05464T1043
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2015-11-19
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.axsome.com

On which stock exchange are Axsome Therapeutics (AXSM) stocks traded?

Axsome Therapeutics (AXSM) stocks are traded on NASDAQ.

What is the ticker of Axsome Therapeutics stocks (AXSM)?

The stock ticker of Axsome Therapeutics’s stocks or in other words, the code is AXSM. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Axsome Therapeutics (AXSM) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Axsome Therapeutics (AXSM) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Axsome Therapeutics (AXSM) stocks traded?

Axsome Therapeutics (AXSM) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Axsome Therapeutics (AXSM) stocks today?

The current price of Axsome Therapeutics stocks on 02.05.2024 is 74.89 dollars. per share.

What is the dynamics of Axsome Therapeutics (AXSM) stocks from the beginning of the year?

Axsome Therapeutics (AXSM) quotes have increased by -2.82% from the beginning of the year up to 74.89 dollars. per 1 stocks.

How much did Axsome Therapeutics (AXSM) stocks increase in мае 2024?

This month Axsome Therapeutics (AXSM) quotes have increased by 0% to 74.89 dollars. per share.

How much are Axsome Therapeutics (AXSM) stocks worth?

Today, on October, 02.05.2024 Axsome Therapeutics’s (AXSM) stocks cost 74.89 dollars..

What is the market capitalization of Axsome Therapeutics (AXSM)?

Capitalization is the market value of Axsome Therapeutics (AXSM) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 02.05.2024, the market capitalization of Axsome Therapeutics (AXSM) is estimated at about 3544527374 dollars.